Cargando…

Counterion coupled (COCO) gemini surfactant capped Ag/Au alloy and Ag@Au core–shell nanoparticles for cancer therapy

Hybrid silver (Ag)–gold (Au) nanoparticles (NPs) with different sizes and compositions were synthesized. Ag/Au alloy and Ag@Au core–shell type NPs were prepared from Ag and Au with various ratios using the COCO gemini surfactant, 1,6-bis (N,N-hexadecyldimethylammonium) adipate (COCOGS), 16-6-16 as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiq, A. Mohammed, Thangam, Ramar, Madhan, Balaraman, Alam, Md. Sayem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075781/
https://www.ncbi.nlm.nih.gov/pubmed/35541822
http://dx.doi.org/10.1039/c9ra06494j
_version_ 1784701760966754304
author Siddiq, A. Mohammed
Thangam, Ramar
Madhan, Balaraman
Alam, Md. Sayem
author_facet Siddiq, A. Mohammed
Thangam, Ramar
Madhan, Balaraman
Alam, Md. Sayem
author_sort Siddiq, A. Mohammed
collection PubMed
description Hybrid silver (Ag)–gold (Au) nanoparticles (NPs) with different sizes and compositions were synthesized. Ag/Au alloy and Ag@Au core–shell type NPs were prepared from Ag and Au with various ratios using the COCO gemini surfactant, 1,6-bis (N,N-hexadecyldimethylammonium) adipate (COCOGS), 16-6-16 as a stabilizer. The formation of the Ag/Au alloy and Ag@Au core–shell was confirmed by UV-visible absorption spectroscopy, high-resolution transmission electron microscopy (HRTEM), energy-dispersive X-ray spectroscopy (EDX) and selected area electron diffraction (SAED) patterns. Depending on the composition of the Ag/Au alloy NPs, the λ(max) values varied from 408 nm to 525 nm. FTIR measurements were used to evaluate the adsorption of the COCO gemini surfactant (16-6-16) on the Ag/Au alloy and Ag@Au core–shell surface. In this present work, we study how to achieve the stability and activity of the COCO gemini surfactant (16-6-16) capped Ag/Au alloy and Ag@Au core–shell NPs for developing novel anti-cancer agents by evaluating their potentials in the Hep-2 cell line model. Thus the developed core–shell NPs were possibly involved in inducing cytotoxicity followed by inhibition of cell proliferation to the cancer cells with apoptosis induction. The developed core–shell NPs might serve as highly applicable agents in the development of next-generation cancer chemotherapeutic agents.
format Online
Article
Text
id pubmed-9075781
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90757812022-05-09 Counterion coupled (COCO) gemini surfactant capped Ag/Au alloy and Ag@Au core–shell nanoparticles for cancer therapy Siddiq, A. Mohammed Thangam, Ramar Madhan, Balaraman Alam, Md. Sayem RSC Adv Chemistry Hybrid silver (Ag)–gold (Au) nanoparticles (NPs) with different sizes and compositions were synthesized. Ag/Au alloy and Ag@Au core–shell type NPs were prepared from Ag and Au with various ratios using the COCO gemini surfactant, 1,6-bis (N,N-hexadecyldimethylammonium) adipate (COCOGS), 16-6-16 as a stabilizer. The formation of the Ag/Au alloy and Ag@Au core–shell was confirmed by UV-visible absorption spectroscopy, high-resolution transmission electron microscopy (HRTEM), energy-dispersive X-ray spectroscopy (EDX) and selected area electron diffraction (SAED) patterns. Depending on the composition of the Ag/Au alloy NPs, the λ(max) values varied from 408 nm to 525 nm. FTIR measurements were used to evaluate the adsorption of the COCO gemini surfactant (16-6-16) on the Ag/Au alloy and Ag@Au core–shell surface. In this present work, we study how to achieve the stability and activity of the COCO gemini surfactant (16-6-16) capped Ag/Au alloy and Ag@Au core–shell NPs for developing novel anti-cancer agents by evaluating their potentials in the Hep-2 cell line model. Thus the developed core–shell NPs were possibly involved in inducing cytotoxicity followed by inhibition of cell proliferation to the cancer cells with apoptosis induction. The developed core–shell NPs might serve as highly applicable agents in the development of next-generation cancer chemotherapeutic agents. The Royal Society of Chemistry 2019-11-20 /pmc/articles/PMC9075781/ /pubmed/35541822 http://dx.doi.org/10.1039/c9ra06494j Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Siddiq, A. Mohammed
Thangam, Ramar
Madhan, Balaraman
Alam, Md. Sayem
Counterion coupled (COCO) gemini surfactant capped Ag/Au alloy and Ag@Au core–shell nanoparticles for cancer therapy
title Counterion coupled (COCO) gemini surfactant capped Ag/Au alloy and Ag@Au core–shell nanoparticles for cancer therapy
title_full Counterion coupled (COCO) gemini surfactant capped Ag/Au alloy and Ag@Au core–shell nanoparticles for cancer therapy
title_fullStr Counterion coupled (COCO) gemini surfactant capped Ag/Au alloy and Ag@Au core–shell nanoparticles for cancer therapy
title_full_unstemmed Counterion coupled (COCO) gemini surfactant capped Ag/Au alloy and Ag@Au core–shell nanoparticles for cancer therapy
title_short Counterion coupled (COCO) gemini surfactant capped Ag/Au alloy and Ag@Au core–shell nanoparticles for cancer therapy
title_sort counterion coupled (coco) gemini surfactant capped ag/au alloy and ag@au core–shell nanoparticles for cancer therapy
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075781/
https://www.ncbi.nlm.nih.gov/pubmed/35541822
http://dx.doi.org/10.1039/c9ra06494j
work_keys_str_mv AT siddiqamohammed counterioncoupledcocogeminisurfactantcappedagaualloyandagaucoreshellnanoparticlesforcancertherapy
AT thangamramar counterioncoupledcocogeminisurfactantcappedagaualloyandagaucoreshellnanoparticlesforcancertherapy
AT madhanbalaraman counterioncoupledcocogeminisurfactantcappedagaualloyandagaucoreshellnanoparticlesforcancertherapy
AT alammdsayem counterioncoupledcocogeminisurfactantcappedagaualloyandagaucoreshellnanoparticlesforcancertherapy